» Articles » PMID: 20942812

Biodistribution, Pharmacokinetics and Metabolism of Interleukin-1 Receptor Antagonist (IL-1RA) Using [¹⁸F]-IL1RA and PET Imaging in Rats

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2010 Oct 15
PMID 20942812
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Positron emission tomography (PET) has the potential to improve our understanding of the preclinical pharmacokinetics and metabolism of therapeutic agents, and is easily translated to clinical studies in humans. However, studies involving proteins radiolabelled with clinically relevant PET isotopes are currently limited. Here we illustrate the potential of PET imaging in a preclinical study of the biodistribution and metabolism of ¹⁸F-labelled IL-1 receptor antagonist ([¹⁸F]IL-1RA) using a novel [¹⁸F]-radiolabelling technique.

Experimental Approach: IL-1RA was radiolabelled by reductive amination on lysine moieties with [¹⁸F]fluoroacetaldehyde. Sprague-Dawley rats were injected intravenously with [¹⁸F]IL-1RA and imaged with a PET camera for 2 h. For the study of IL-1RA metabolites by ex vivoγ-counting of samples, rats were killed 20 min, 1 h or 2 h after injection of [¹⁸F]IL-1RA.

Key Results: [¹⁸F]IL-1RA distribution into the major organs of interest was as follows: kidneys >> liver > lungs >> brain. In lungs and liver, [¹⁸F]IL-1RA uptake peaked within 1 min post-injection then decreased rapidly to reach a plateau from 10 min post-injection. In the brain, the uptake exhibited slower pharmacokinetics with a smaller post-injection peak and a plateau from 6 min onward. IL-1RA was rapidly metabolized and these metabolites represented ∼40% of total activity in plasma and ∼80% in urine, 20 min after injection. CONCLUSIONS AND IMPLICATIONS Preclinical PET imaging is a feasible method of assessing the biodistribution of new biological compounds of therapeutic interest rapidly. The biodistribution of [¹⁸F]IL-1RA reported here is in agreement with an earlier study suggesting low uptake in the normal brain, with rapid metabolism and excretion via the kidneys.

Citing Articles

P2X7 receptor inhibition alleviates mania-like behavior independently of interleukin-1β.

Goloncser F, Baranyi M, Tod P, Maacz F, Sperlagh B iScience. 2024; 27(3):109284.

PMID: 38444608 PMC: 10914489. DOI: 10.1016/j.isci.2024.109284.


Current and potential roles of immuno-PET/-SPECT in CAR T-cell therapy.

Mulgaonkar A, Udayakumar D, Yang Y, Harris S, Oz O, Ramakrishnan Geethakumari P Front Med (Lausanne). 2023; 10:1199146.

PMID: 37441689 PMC: 10333708. DOI: 10.3389/fmed.2023.1199146.


Expression and characterization of recombinant IL-1Ra in Aspergillus oryzae as a system.

Mahmoudi Azar L, Karaman E, Beyaz B, Goktan I, Eyupoglu A, Kizilel S BMC Biotechnol. 2023; 23(1):15.

PMID: 37340430 PMC: 10283290. DOI: 10.1186/s12896-023-00785-7.


Measurement of Protein Synthesis Rate in Rat by [C]Leucine PET Imaging: Application to the TgF344-AD Model of Alzheimer's Disease.

Bochicchio D, Christie L, Lawrence C, Herholz K, Parker C, Hinz R Mol Imaging Biol. 2022; 25(3):596-605.

PMID: 36538180 PMC: 10172255. DOI: 10.1007/s11307-022-01796-0.


Postoperative cognitive dysfunction is made persistent with morphine treatment in aged rats.

Muscat S, Deems N, DAngelo H, Kitt M, Grace P, Andersen N Neurobiol Aging. 2020; 98:214-224.

PMID: 33341652 PMC: 7870544. DOI: 10.1016/j.neurobiolaging.2020.11.008.


References
1.
Pott Godoy M, Tarelli R, Ferrari C, Sarchi M, Pitossi F . Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. Brain. 2008; 131(Pt 7):1880-94. PMC: 2442423. DOI: 10.1093/brain/awn101. View

2.
Shaftel S, Kyrkanides S, Olschowka J, Miller J, Johnson R, OBanion M . Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. J Clin Invest. 2007; 117(6):1595-604. PMC: 1878531. DOI: 10.1172/JCI31450. View

3.
Lee B, Ahn S, Doo H, Yim S, Lee H, Jin S . Susceptibility for ischemic stroke in Korean population is associated with polymorphisms of the interleukin-1 receptor antagonist and tumor necrosis factor-alpha genes, but not the interleukin-1beta gene. Neurosci Lett. 2004; 357(1):33-6. DOI: 10.1016/j.neulet.2003.12.041. View

4.
Dinarello C . Interleukin-1. Cytokine Growth Factor Rev. 1998; 8(4):253-65. DOI: 10.1016/s1359-6101(97)00023-3. View

5.
Maroy R, Boisgard R, Comtat C, Jego B, Fontyn Y, Jan S . Quantitative organ time activity curve extraction from rodent PET images without anatomical prior. Med Phys. 2010; 37(4):1507-17. DOI: 10.1118/1.3327454. View